cyclosporine has been researched along with Carotid Arteriopathies, Traumatic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edelman, ER; Groothuis, A; Methe, H; Nanasato, M; Spognardi, AM | 1 |
Garvey, SM; Lee, MY; Ripley, ML; Wamhoff, BR | 1 |
Bennett, MR; Biessen, EA; Bot, I; Bot, M; Overkleeft, H; Sliedregt, K; van Berkel, TJ; van der Marel, GA; van Heiningen, SH; Xu, X; Yu, H | 1 |
Billingham, ME; Dzau, VJ; Gregory, CR; Huang, X; Morris, RE; Pratt, RE; Shorthouse, R | 1 |
Billingham, ME; Dzau, VJ; Gregory, CR; Huie, P; Morris, RE; Pratt, RE; Shorthouse, R | 1 |
5 other study(ies) available for cyclosporine and Carotid Arteriopathies, Traumatic
Article | Year |
---|---|
T-helper 2 cells are essential for modulation of vascular repair by allogeneic endothelial cells.
Topics: Animals; Carotid Artery Injuries; Cell Transplantation; Cyclosporine; Endothelium, Vascular; Immunoglobulin G; Immunosuppressive Agents; Interleukin-4; Models, Animal; Spleen; Swine; Th2 Cells; Transplantation, Homologous | 2010 |
Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.
Topics: Animals; Base Sequence; Becaplermin; Blood Coagulation Factors; Calcineurin; Calcineurin Inhibitors; Carotid Artery Injuries; Catheterization; Cells, Cultured; Cyclosporine; Gene Expression Regulation; Genome; Models, Animal; Molecular Sequence Data; Muscle, Smooth, Vascular; NFATC Transcription Factors; Oligonucleotide Array Sequence Analysis; Phenotype; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrazoles; Rats; Receptors, Cell Surface | 2011 |
Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Topics: Amino Acid Motifs; Animals; Apolipoproteins E; Calcineurin; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Proliferation; Chlorocebus aethiops; COS Cells; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Hyperplasia; Immunosuppressive Agents; Jurkat Cells; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; NFATC Transcription Factors; Peptides; Peritonitis; Recurrence; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes; Transfection | 2012 |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Carotid Artery Injuries; Catheterization; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Mycophenolic Acid; Polyenes; Rats; Rats, Sprague-Dawley; Sirolimus; Tacrolimus; Time Factors; Tunica Intima; Vascular Patency | 1995 |
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Topics: Animals; Aorta; Carotid Arteries; Carotid Artery Injuries; Cell Division; Cells, Cultured; Cyclosporine; Guanidines; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Mycophenolic Acid; Polyenes; Rats; Rats, Sprague-Dawley; Sirolimus; Tacrolimus | 1993 |